Clinical Trials Directory

Trials / Completed

CompletedNCT03311620

Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle Aspirate

TH-112: Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle Aspirate

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Fox Chase Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Needle biopsy samples are routinely collected to evaluate cytomorphology, immunohistochemical markers and for mutational analysis. With regular use of immunotheraputic interventions, needle biospy has become more frequent and requires bigger samples for an increasing battery of tests. There has been no clear consensus on which biopsy needle yields the best biopsy sample. It is unclear if large 19g needle offers better yield than a 22 g needle. Although previous studies comparing 21, 22 and 19g needles have suggested that larger needles yield larger biopsy sizes, conflictng studies have shown that larger biopsies lead to bloodier samples with potentially smaller fragments of tissue, offering no improvement in diagnostic, yield, adequacy or sample size. This study compares biopsy samples collected using 19g and 22g needles from patients of non small cell lung cancer (NSCLC) scheduled to undergo endobronchial ultrasound (EBUS) and transbroncial needle aspiration (TBNA).

Detailed description

Primary Objective To compare the diagnostic yield of 22g and 19g EBUS transbronchial needle aspirate (TBNA) Secondary Objectives 1. To compare the sample adequacy of 22g and 19g EBUS TBNA 2. To compare the sample quality of 22g and 19 g EBUS TBNA

Conditions

Interventions

TypeNameDescription
PROCEDUREEndobronchial ultrasound (EBUS) transbronchial needle aspirate (TBNA)Biopsy samples will be collected from patients scheduled to undergo EBUS TBNA using 19g and 22g needles

Timeline

Start date
2018-05-15
Primary completion
2020-06-08
Completion
2020-06-08
First posted
2017-10-17
Last updated
2020-10-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03311620. Inclusion in this directory is not an endorsement.